Search - tctmd.com

Displaying 21 - 40 of 130

Sort: Relevancy | Date

Presentation TCT 2023

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

Presenter: Rahul Sharma

October 26, 2023

Presentation TCT 2023

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

Presenter: Fabio Enrique Posas

October 26, 2023

Presentation TCT 2023

TCT 905: Acute Valve Leaflet Thrombosis After Transcatheter Aortic Valve Replacement

Presenter: Dhruv Sarma

October 26, 2023

Presentation TCT 2023

Subclinical Leaflet Thrombosis: Detection and Management

Presenter: Rahul Sharma

October 25, 2023

Presentation TCT 2023

Subclinical Leaflet Thrombosis: More Important Than You Think

Presenter: Miho Fukui

October 25, 2023

Presentation TCT 2023

Subclinical Leaflet Thrombosis: A Benign Imaging Finding

Presenter: Jonathon Leipsic

October 25, 2023

Presentation TCT 2023

A Challenging Case of Subclinical Leaflet Thrombosis

Presenter: Andrew Luxhoj

October 25, 2023

Presentation TCT 2023

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

Presenter: Shubhadarshini Pawar

October 24, 2023

Presentation TCT 2023

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

Presenter: Yousef Darestani

October 24, 2023

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Caitlin E. Cox

May 19, 2023

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

Presentation TCT 2022

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

Presenter: Mina Shafiei

September 19, 2022

Presentation TCT 2022

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Presenter: Ali Azadani

September 19, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

Advertisement

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

TCT 905: Acute Valve Leaflet Thrombosis After Transcatheter Aortic Valve Replacement

Subclinical Leaflet Thrombosis: Detection and Management

Subclinical Leaflet Thrombosis: More Important Than You Think

Subclinical Leaflet Thrombosis: A Benign Imaging Finding

A Challenging Case of Subclinical Leaflet Thrombosis

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content